Overview
Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
Status:
Terminated
Terminated
Trial end date:
2012-03-01
2012-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166. 100 Type I and 100 Type II diabetics will be enrolled. Each subject will undergo 6 PFT assessments over the course of the parent study.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Mannkind CorporationTreatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:- Enrollment in one of three parent trials (MKC-TI-161, MKC-TI-162 or MKC-TI-166)
Exclusion Criteria:
- Subjects who are unable to perform PFTs that meet American Thoracic Society/European
Respiratory Society (ATS/ERS) quality recommendations for acceptability and
repeatability will be excluded from this study